Interpretation of American Diabetes Association Standards of Medical Care in Diabetes-2018_West China Medical Journal

Authors：

TANG Lizhi ,  TONG Nanwei

Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P. R. China;

Corresponding author：

TONG Nanwei, Email: tongnw@scu.edu.cn

Keywords：

American Diabetes Association; Diabetes mellitus; Diagnosis; Treatment; Management; Assessment

DOI：

10.7507/1002-0179.201803136

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

The Standards of Medical Care in Diabetes released by the American Diabetes Association (ADA) is one of the most important guidelines for clinicians. Based on the latest evidence of clinical studies, the Standards of Medical Care in Diabetes is annually updated by ADA. The statements of ADA on diagnosis, assessment, and management in diabetes are recommended for clinicians, patients, and researchers. The latest edition of Standards of Medical Care in Diabetes was published in a supplementary issue of Diabetes Care in January 2018. This interpretation will focus on the updated contents and their best evidence and clinical importance in this guideline.

Citation： TANG Lizhi, TONG Nanwei. Interpretation of American Diabetes Association Standards of Medical Care in Diabetes-2018. West China Medical Journal, 2018, 33(5): 513-519. doi: 10.7507/1002-0179.201803136 Copy

1.	American Diabetes Association. Standards of medical care in diabetes-2018. Diabetes care 2018, 41(Suppl 1): S1-S153.
2.	Wallia A, Illuri V, Molitch ME. Diabetes care after transplant: definitions, risk factors, and clinical management. Med Clin North Am, 2016, 100(3): 535-550.
3.	Thomas MC, Mathew TH, Russ GR, et al. Early peri-operative glycaemic control and allograft rejection in patients with diabetes mellitus: a pilot study. Transplantation, 2001, 72(7): 1321-1324.
4.	Wheeler ML, Dunbar SA, Jaacks LM, et al. Macronutrients, food groups, and eating patterns in the management of diabetes: a systematic review of the literature, Diabetes Care, 2012, 35(2): 434-445.
5.	Van Wyk HJ, Davis RE, Davies JS. A critical review of low-carbohydrate diets in people with type 2 diabetes. Diabet Med, 2016, 33(2): 148-157.
6.	Sega R, Facchetti R, Bombelli M, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation, 2005, 111(14): 1777-1783.
7.	Omboni S, Gazzola T, Carabelli G, et al. Clinical usefulness and cost effectiveness of home blood pressure telemonitoring: meta-analysis of randomized controlled studies. J Hypertens, 2013, 31(3): 455-467; discussion 467-468.
8.	Iliescu R, Lohmeier TE, Tudorancea I, et al. Renal denervation for the treatment of resistant hypertension: review and clinical perspective. Am J Physiol Renal Physiol, 2015, 309(7): F583-F594.
9.	Wanner C, Inzucchi SE, Lachin JM, et al. Empagliflozin and progression of kidney disease in type 2 diabetes. N Engl J Med, 2016, 375(4): 323-334.
10.	Marso SP, Daniels GH, Brown-Frandsen K, et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med, 2016, 375(4): 311-322.
11.	Writing Committee for the Diabetic Retinopathy Clinical Research Network, Gross JG, Glassman AR, et al. Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial. JAMA, 2015, 314(20): 2137-2146.
12.	Elraiyah T, Tsapas A, Prutsky G, et al. A systematic review and meta-analysis of adjunctive therapies in diabetic foot ulcers. J Vasc Surg, 2016, 63(2 Suppl): 46S-58S.e1.
13.	Game FL, Apelqvist J, Attinger C, et al. Effectiveness of interventions to enhance healing of chronic ulcers of the foot in diabetes: a systematic review. Diabetes Metab Res Rev, 2016, 32(Suppl 1): 154-168.
14.	Tosur M. Autoimmune diseases in children and adults with type 1 diabetes from the T1D exchange clinic registry. Clin pediatr (Phila), 2018, 57(5): 621.
15.	Werner EF, Hauspurg AK, Rouse DJ. A cost-benefit analysis of low-dose aspirin prophylaxis for the prevention of preeclampsia in the United States. Obstet Gynecol, 2015, 126(6): 1242-1250.

1. American Diabetes Association. Standards of medical care in diabetes-2018. Diabetes care 2018, 41(Suppl 1): S1-S153.
2. Wallia A, Illuri V, Molitch ME. Diabetes care after transplant: definitions, risk factors, and clinical management. Med Clin North Am, 2016, 100(3): 535-550.
3. Thomas MC, Mathew TH, Russ GR, et al. Early peri-operative glycaemic control and allograft rejection in patients with diabetes mellitus: a pilot study. Transplantation, 2001, 72(7): 1321-1324.
4. Wheeler ML, Dunbar SA, Jaacks LM, et al. Macronutrients, food groups, and eating patterns in the management of diabetes: a systematic review of the literature, Diabetes Care, 2012, 35(2): 434-445.
5. Van Wyk HJ, Davis RE, Davies JS. A critical review of low-carbohydrate diets in people with type 2 diabetes. Diabet Med, 2016, 33(2): 148-157.
6. Sega R, Facchetti R, Bombelli M, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation, 2005, 111(14): 1777-1783.
7. Omboni S, Gazzola T, Carabelli G, et al. Clinical usefulness and cost effectiveness of home blood pressure telemonitoring: meta-analysis of randomized controlled studies. J Hypertens, 2013, 31(3): 455-467; discussion 467-468.
8. Iliescu R, Lohmeier TE, Tudorancea I, et al. Renal denervation for the treatment of resistant hypertension: review and clinical perspective. Am J Physiol Renal Physiol, 2015, 309(7): F583-F594.
9. Wanner C, Inzucchi SE, Lachin JM, et al. Empagliflozin and progression of kidney disease in type 2 diabetes. N Engl J Med, 2016, 375(4): 323-334.
10. Marso SP, Daniels GH, Brown-Frandsen K, et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med, 2016, 375(4): 311-322.
11. Writing Committee for the Diabetic Retinopathy Clinical Research Network, Gross JG, Glassman AR, et al. Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial. JAMA, 2015, 314(20): 2137-2146.
12. Elraiyah T, Tsapas A, Prutsky G, et al. A systematic review and meta-analysis of adjunctive therapies in diabetic foot ulcers. J Vasc Surg, 2016, 63(2 Suppl): 46S-58S.e1.
13. Game FL, Apelqvist J, Attinger C, et al. Effectiveness of interventions to enhance healing of chronic ulcers of the foot in diabetes: a systematic review. Diabetes Metab Res Rev, 2016, 32(Suppl 1): 154-168.
14. Tosur M. Autoimmune diseases in children and adults with type 1 diabetes from the T1D exchange clinic registry. Clin pediatr (Phila), 2018, 57(5): 621.
15. Werner EF, Hauspurg AK, Rouse DJ. A cost-benefit analysis of low-dose aspirin prophylaxis for the prevention of preeclampsia in the United States. Obstet Gynecol, 2015, 126(6): 1242-1250.

West China Medical Journal

Interpretation of American Diabetes Association Standards of Medical Care in Diabetes-2018

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content